HEADER CYTOKINE 22-OCT-02 1N26 TITLE CRYSTAL STRUCTURE OF THE EXTRA-CELLULAR DOMAINS OF HUMAN INTERLEUKIN-6 TITLE 2 RECEPTOR ALPHA CHAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: IL-6 RECEPTOR ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: IL-6R EXTRAL-CELLULAR DOMAINS; COMPND 5 SYNONYM: INTERLEUKIN-6 RECEPTOR ALPHA CHAIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IL6R; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: CHO; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: LEC3.2.8.1; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PEE14SIL6RL325 KEYWDS TRANSMEMBRANE, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, CYTOKINE EXPDTA X-RAY DIFFRACTION AUTHOR J.N.VARGHESE,R.L.MORITZ,M.-Z.LOU,A.VAN DONKELAAR,H.JI,N.IVANCIC, AUTHOR 2 K.M.BRANSON,N.E.HALL,R.J.SIMPSON REVDAT 6 03-APR-24 1N26 1 REMARK REVDAT 5 15-NOV-23 1N26 1 REMARK HETSYN SSBOND LINK REVDAT 4 29-JUL-20 1N26 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 13-JUL-11 1N26 1 VERSN REVDAT 2 24-FEB-09 1N26 1 VERSN REVDAT 1 18-DEC-02 1N26 0 JRNL AUTH J.N.VARGHESE,R.L.MORITZ,M.-Z.LOU,A.VAN DONKELAAR,H.JI, JRNL AUTH 2 N.IVANCIC,K.M.BRANSON,N.E.HALL,R.J.SIMPSON JRNL TITL STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE HUMAN JRNL TITL 2 INTERLEUKIN-6 RECEPTOR ALPHA-CHAIN. JRNL REF PROC.NATL.ACAD.SCI.USA V. 99 15959 2002 JRNL REFN ISSN 0027-8424 JRNL PMID 12461182 JRNL DOI 10.1073/PNAS.232432399 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 15298 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 731 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2360 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 137 REMARK 3 SOLVENT ATOMS : 83 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.36900 REMARK 3 B22 (A**2) : -6.36900 REMARK 3 B33 (A**2) : 12.73700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 BOND ANGLES (DEGREES) : 1.960 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 6.394 ; 3.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 7.619 ; 4.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 7.922 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 9.105 ; 4.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1N26 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-OCT-02. REMARK 100 THE DEPOSITION ID IS D_1000017425. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL; NULL; NULL; NULL REMARK 200 TEMPERATURE (KELVIN) : 100; 100; 100; 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 4 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N; N; Y; NULL REMARK 200 RADIATION SOURCE : ROTATING ANODE; ROTATING ANODE; REMARK 200 APS; NULL REMARK 200 BEAMLINE : NULL; NULL; 14-BM-C; NULL REMARK 200 X-RAY GENERATOR MODEL : MACSCIENCE; RIGAKU RUH3R; NULL; REMARK 200 NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M; M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418; 1.5418; 1.0; NULL REMARK 200 MONOCHROMATOR : YALE MIRRORS; MONOCAPILLARY REMARK 200 OPTICS; MONOCAPILLARY OPTICS; REMARK 200 APS BM14C REMARK 200 OPTICS : YALE MIRRORS; MONOCAPILLARY REMARK 200 OPTICS; APS BM14C OPTICS; NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE; IMAGE PLATE; CCD; REMARK 200 NULL REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II; RIGAKU RAXIS REMARK 200 IV; ADSC QUANTUM 4; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 18.60 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 39.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.57000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH; SINGLE REMARK 200 WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: AB INITIO BUILT INTO MIR MAP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULPHATE, PEG 3350, SODIUM REMARK 280 CITRATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 151.69400 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 25.56500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 25.56500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 227.54100 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 25.56500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 25.56500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 75.84700 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 25.56500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 25.56500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 227.54100 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 25.56500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 25.56500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 75.84700 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 151.69400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 76.69500 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 25.56500 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -75.84700 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 806 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 300 REMARK 465 SER A 301 REMARK 465 PRO A 302 REMARK 465 PRO A 303 REMARK 465 ALA A 304 REMARK 465 GLU A 305 REMARK 465 ASN A 306 REMARK 465 GLU A 307 REMARK 465 VAL A 308 REMARK 465 SER A 309 REMARK 465 THR A 310 REMARK 465 PRO A 311 REMARK 465 MET A 312 REMARK 465 GLN A 313 REMARK 465 ALA A 314 REMARK 465 LEU A 315 REMARK 465 THR A 316 REMARK 465 THR A 317 REMARK 465 ASN A 318 REMARK 465 LYS A 319 REMARK 465 ASP A 320 REMARK 465 ASP A 321 REMARK 465 ASP A 322 REMARK 465 ASN A 323 REMARK 465 ILE A 324 REMARK 465 LEU A 325 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ARG A 82 REMARK 475 ASN A 136 REMARK 475 SER A 137 REMARK 475 PRO A 138 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 5 NE CZ NH1 NH2 REMARK 480 GLU A 10 CD OE1 OE2 REMARK 480 ARG A 13 CB CG CD NE CZ NH1 NH2 REMARK 480 GLU A 32 CG CD OE1 OE2 REMARK 480 LYS A 244 CD CE NZ REMARK 480 LYS A 252 CD CE NZ REMARK 480 SER A 299 O OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 273 CA - CB - CG ANGL. DEV. = 13.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 2 -126.33 -110.75 REMARK 500 PRO A 3 170.90 -37.42 REMARK 500 ARG A 4 -114.12 -25.24 REMARK 500 VAL A 11 131.97 61.45 REMARK 500 GLU A 32 154.94 -48.23 REMARK 500 ASN A 36 2.22 -63.21 REMARK 500 SER A 50 -142.66 -73.53 REMARK 500 HIS A 51 63.55 -169.38 REMARK 500 PRO A 52 122.60 -26.16 REMARK 500 SER A 66 54.98 19.33 REMARK 500 VAL A 67 151.76 -43.56 REMARK 500 ALA A 80 -61.19 69.02 REMARK 500 ARG A 82 -52.69 -159.65 REMARK 500 SER A 122 171.42 -57.51 REMARK 500 GLN A 135 -134.66 -105.14 REMARK 500 ALA A 139 106.64 -40.95 REMARK 500 GLU A 151 -77.44 -55.66 REMARK 500 CYS A 192 53.14 -100.58 REMARK 500 ALA A 209 131.08 -35.51 REMARK 500 TRP A 219 164.60 176.34 REMARK 500 SER A 227 138.82 61.02 REMARK 500 ASP A 262 34.40 -140.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IL6 RELATED DB: PDB REMARK 900 1IL6 CONTAINS SOLUTION STRUCTURE OF THE SAME PROTEIN REMARK 900 RELATED ID: 1I1R RELATED DB: PDB REMARK 900 1I1R CONTAINS CRYSTAL STRUCTURE OF THE BETA CHAIN COMPLEXED WITH REMARK 900 GP130 OF THE SAME PROTEIN REMARK 900 RELATED ID: 1N2Q RELATED DB: PDB REMARK 900 1N2Q CONTAINS THEORETICAL MODEL STRUCTURE OF THE BETA CHAIN REMARK 900 COMPLEXED WITH GP130 OF THE SAME PROTEIN DBREF 1N26 A 1 325 UNP P08887 IL6A_HUMAN 20 344 SEQRES 1 A 325 LEU ALA PRO ARG ARG CYS PRO ALA GLN GLU VAL ALA ARG SEQRES 2 A 325 GLY VAL LEU THR SER LEU PRO GLY ASP SER VAL THR LEU SEQRES 3 A 325 THR CYS PRO GLY VAL GLU PRO GLU ASP ASN ALA THR VAL SEQRES 4 A 325 HIS TRP VAL LEU ARG LYS PRO ALA ALA GLY SER HIS PRO SEQRES 5 A 325 SER ARG TRP ALA GLY MET GLY ARG ARG LEU LEU LEU ARG SEQRES 6 A 325 SER VAL GLN LEU HIS ASP SER GLY ASN TYR SER CYS TYR SEQRES 7 A 325 ARG ALA GLY ARG PRO ALA GLY THR VAL HIS LEU LEU VAL SEQRES 8 A 325 ASP VAL PRO PRO GLU GLU PRO GLN LEU SER CYS PHE ARG SEQRES 9 A 325 LYS SER PRO LEU SER ASN VAL VAL CYS GLU TRP GLY PRO SEQRES 10 A 325 ARG SER THR PRO SER LEU THR THR LYS ALA VAL LEU LEU SEQRES 11 A 325 VAL ARG LYS PHE GLN ASN SER PRO ALA GLU ASP PHE GLN SEQRES 12 A 325 GLU PRO CYS GLN TYR SER GLN GLU SER GLN LYS PHE SER SEQRES 13 A 325 CYS GLN LEU ALA VAL PRO GLU GLY ASP SER SER PHE TYR SEQRES 14 A 325 ILE VAL SER MET CYS VAL ALA SER SER VAL GLY SER LYS SEQRES 15 A 325 PHE SER LYS THR GLN THR PHE GLN GLY CYS GLY ILE LEU SEQRES 16 A 325 GLN PRO ASP PRO PRO ALA ASN ILE THR VAL THR ALA VAL SEQRES 17 A 325 ALA ARG ASN PRO ARG TRP LEU SER VAL THR TRP GLN ASP SEQRES 18 A 325 PRO HIS SER TRP ASN SER SER PHE TYR ARG LEU ARG PHE SEQRES 19 A 325 GLU LEU ARG TYR ARG ALA GLU ARG SER LYS THR PHE THR SEQRES 20 A 325 THR TRP MET VAL LYS ASP LEU GLN HIS HIS CYS VAL ILE SEQRES 21 A 325 HIS ASP ALA TRP SER GLY LEU ARG HIS VAL VAL GLN LEU SEQRES 22 A 325 ARG ALA GLN GLU GLU PHE GLY GLN GLY GLU TRP SER GLU SEQRES 23 A 325 TRP SER PRO GLU ALA MET GLY THR PRO TRP THR GLU SER SEQRES 24 A 325 ARG SER PRO PRO ALA GLU ASN GLU VAL SER THR PRO MET SEQRES 25 A 325 GLN ALA LEU THR THR ASN LYS ASP ASP ASP ASN ILE LEU MODRES 1N26 ASN A 36 ASN GLYCOSYLATION SITE MODRES 1N26 ASN A 74 ASN GLYCOSYLATION SITE MODRES 1N26 ASN A 202 ASN GLYCOSYLATION SITE MODRES 1N26 ASN A 226 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET MAN B 4 11 HET NDG B 5 14 HET NAG C 1 14 HET NAG C 2 14 HET NAG A 621 14 HET NAG A 641 14 HET SO4 A 701 5 HET SO4 A 702 5 HET CYS A 692 7 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION HETNAM CYS CYSTEINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE FORMUL 2 NAG 6(C8 H15 N O6) FORMUL 2 BMA C6 H12 O6 FORMUL 2 MAN C6 H12 O6 FORMUL 2 NDG C8 H15 N O6 FORMUL 6 SO4 2(O4 S 2-) FORMUL 8 CYS C3 H7 N O2 S FORMUL 9 HOH *83(H2 O) HELIX 1 1 GLN A 68 SER A 72 5 5 HELIX 2 2 LYS A 252 GLN A 255 5 4 SHEET 1 A 5 VAL A 15 SER A 18 0 SHEET 2 A 5 THR A 86 VAL A 91 1 O LEU A 90 N LEU A 16 SHEET 3 A 5 GLY A 73 TYR A 78 -1 N TYR A 75 O VAL A 87 SHEET 4 A 5 THR A 38 ARG A 44 -1 N HIS A 40 O TYR A 78 SHEET 5 A 5 SER A 53 MET A 58 -1 O GLY A 57 N VAL A 39 SHEET 1 B 2 VAL A 24 THR A 27 0 SHEET 2 B 2 ARG A 61 LEU A 64 -1 O LEU A 64 N VAL A 24 SHEET 1 C 7 SER A 101 PHE A 103 0 SHEET 2 C 7 VAL A 111 TRP A 115 -1 O GLU A 114 N SER A 101 SHEET 3 C 7 LYS A 154 LEU A 159 -1 O PHE A 155 N TRP A 115 SHEET 4 C 7 GLU A 140 SER A 149 -1 N GLN A 147 O SER A 156 SHEET 5 C 7 LYS A 126 PHE A 134 -1 N VAL A 131 O PHE A 142 SHEET 6 C 7 PHE A 168 SER A 177 -1 O SER A 172 N LEU A 130 SHEET 7 C 7 GLY A 180 PHE A 183 -1 O GLY A 180 N SER A 177 SHEET 1 D 7 SER A 101 PHE A 103 0 SHEET 2 D 7 VAL A 111 TRP A 115 -1 O GLU A 114 N SER A 101 SHEET 3 D 7 LYS A 154 LEU A 159 -1 O PHE A 155 N TRP A 115 SHEET 4 D 7 GLU A 140 SER A 149 -1 N GLN A 147 O SER A 156 SHEET 5 D 7 LYS A 126 PHE A 134 -1 N VAL A 131 O PHE A 142 SHEET 6 D 7 PHE A 168 SER A 177 -1 O SER A 172 N LEU A 130 SHEET 7 D 7 GLN A 187 GLN A 190 -1 O GLN A 187 N VAL A 171 SHEET 1 E 3 ALA A 201 ALA A 207 0 SHEET 2 E 3 LEU A 215 GLN A 220 -1 O SER A 216 N THR A 206 SHEET 3 E 3 HIS A 257 ILE A 260 -1 O CYS A 258 N VAL A 217 SHEET 1 F 4 THR A 247 MET A 250 0 SHEET 2 F 4 LEU A 232 ALA A 240 -1 N LEU A 236 O TRP A 249 SHEET 3 F 4 HIS A 269 GLU A 277 -1 O VAL A 270 N ARG A 239 SHEET 4 F 4 ALA A 291 GLY A 293 -1 O ALA A 291 N VAL A 271 SSBOND 1 CYS A 6 CYS A 174 1555 1555 2.03 SSBOND 2 CYS A 28 CYS A 77 1555 1555 2.02 SSBOND 3 CYS A 102 CYS A 113 1555 1555 2.06 SSBOND 4 CYS A 146 CYS A 157 1555 1555 2.05 SSBOND 5 CYS A 192 CYS A 692 1555 1555 2.03 LINK ND2 ASN A 36 C1 NAG A 641 1555 1555 1.45 LINK ND2 ASN A 74 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN A 202 C1 NAG A 621 1555 1555 1.45 LINK ND2 ASN A 226 C1 NAG B 1 1555 1555 1.46 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.39 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.40 LINK O6 BMA B 3 C1 MAN B 4 1555 1555 1.41 LINK O4 MAN B 4 C1 NDG B 5 1555 1555 1.41 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.40 CRYST1 51.130 51.130 303.388 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019558 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019558 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003296 0.00000